The bolus effective dose of ketamine required to prevent withdrawal movement on injection of rocuronium was determined in 27 paediatric patients undergoing elective surgery. A predetermined dose of ketamine was given intravenously on arrival in the operating room and anaesthesia (2.5% thiopental, 5 mg/kg) was administered 1 min later. After loss of consciousness, 1% rocuronium at 0.6 mg/kg was injected over 5 s and the presence or absence of withdrawal movement recorded. The effective dose of ketamine was determined using a modified Dixon up-and-down method with a step size of 0.1 mg/kg, successful prevention of withdrawal movement being defined as no response or movement at the wrist only. The bolus effective dose of ketamine for preventing withdrawal movement after injection of rocuronium following thiopental anaesthesia in 50% of paediatric patients (ED 50 ) was 0.21 mg/kg according to the modified Dixon up-anddown method. Probit analysis indicated an ED 50 of 0.18 mg/kg and an ED 95 of 0.33 mg/kg. The latter was the most satisfactory dose in the clinical setting. 0.18 mg/kg and the ED 95 was 0.33 mg/kg, the latter being the most satisfactory in the clinical setting.
Introduction
Injection of rocuronium after the administration of anaesthesia is commonly associated with withdrawal movement of the injection site or generalized movement of the body. 1 -4 In children the response is more intense than has been reported in adults, many children showing generalized movement. 5 This generalized spontaneous withdrawal movement can lead to complications ranging from dislodgement of the intravenous line to pulmonary aspiration secondary to gastric regurgitation. 6 The withdrawal movement may be a direct consequence of pain associated with rocuronium administration. 7 Several methods have been suggested for attenuating rocuronium-induced withdrawal movements and have met with varying success. 5,8 -14 Ketamine pretreatment has been shown to reduce the pain associated with the injection of rocuronium in adults. 15 
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Moreover, ketamine has been shown to decrease the incidence and severity of withdrawal movements in paediatric patients aged 1 -6 years; 16 however, there are no published studies investigating the effective dose of ketamine for preventing withdrawal movement associated with rocuronium injection in paediatric patients.
The aim of the present study was to determine the bolus effective dose of ketamine required to prevent withdrawal movements on injection of rocuronium after thiopental anaesthesia in paediatric patients.
Patients and methods

PATIENTS
Consecutive paediatric patients who were to undergo elective surgery at Ajou University Hospital, Suwon, Republic of Korea and who had an American Society of Anesthesiologists (ASA) physical status of I or II were recruited into the study. Patients with a history of neurological problems or allergies and patients who had taken medicine that might affect the study results, such as sedatives or analgesics, within the previous 24 h were excluded from the study.
Written informed consent to participate in the study was obtained from the patients' parents and the study protocol was approved by the Institutional Review Board of Ajou University, Suwon, Republic of Korea.
KETAMINE ADMINISTRATION
A 24-gauge venous cannula was placed in the dorsum of the hand while the patient was on the ward or in the out-patient surgery room. Patients were then transferred to the operating room in their parents' arms. No premedication was given before the administration of anaesthesia.
All patients were monitored by electrocardiography, pulse oximetry and non-invasive blood pressure measurement.
A predetermined bolus dose of ketamine (see below) was injected via the venous line and anaesthesia (2.5% thiopental at 5 mg/kg) was administered 1 min later. After loss of consciousness, 1% rocuronium at 0.6 mg/kg was injected over 5 s. The presence or absence of withdrawal movement was observed and recorded by an anaesthetist blinded to the dose of injected ketamine. Manual ventilation with sevoflurane and intubation were then performed.
The bolus dose of ketamine for each patient was determined on the basis of the response of the previously tested patient, using a modification of the Dixon up-anddown method 17 with a step size of 0.1 mg/kg. The first patient was given 0.5 mg/kg ketamine. If prevention of withdrawal movement was successful, in the next patient the ketamine dose was decreased by 0.1 mg/kg and, if it was not successful, the dose was increased by 0.1 mg/kg. Withdrawal movement was evaluated according to the following scoring system: 0, no response; 1, movement at the wrist only; 2, movement/withdrawal involving the arm only (elbow/shoulder); 3, generalized response, withdrawal or movement of more than one extremity, coughing, or holding the breath. 1 Successful prevention of withdrawal movement was defined as a score of 0 or 1.
STATISTICAL ANALYSES
The mean ± SD of the data were calculated. The effective dose of ketamine for preventing withdrawal movement on injection of rocuronium in 50% of paediatric patients (i.e. the ED 50 ) was determined by calculating the mean of crossover midpoints of all independent pairs of patients from the Dixon up-and-down data (i.e. failure followed by successful prevention of withdrawal movement). The up-and-down data were also subjected to probit analysis, SK Min, SY Lee, KS Park et al. Ketamine dose preventing rocuronium-induced movement in children which enabled derivation of the ED 50 and ED 95 with 95% confidence limits. The statistical analysis software used was SPSS ® version 11.0 (SPSS Inc., Chicago, IL, USA).
Results
Although children of all ages were eligible for the study, those recruited were aged between 1 and 7 years because of their availability at Ajou University Hospital, Suwon, Republic of Korea. A total of 27 patients (22 males, five females) were enrolled in the study; their mean ± SD age was 3.6 ± 1.8 years and body weight was 17.1 ± 4.4 kg. Individual doseresponse data within the up-and-down sequence are shown in Fig. 1 .
A total of eight independent crossover pairs were collected. Using the modified up-anddown method the bolus ED 50 of ketamine required for the prevention of withdrawal movement after injection of rocuronium was determined to be 0.21 ± 0.07 mg/kg. Using probit analysis, the ED 50 and ED 95 of ketamine were calculated to be 0.18 mg/kg (95% confidence limits 0.10, 0.25 mg/kg) and 0.33 mg/kg (95% confidence limits 0.26, 0.72 mg/kg), respectively. No patients demonstrated complications such as apnoea, hypoxaemia or laryngospasm as a result of ketamine administration. 
Discussion
Using a modified Dixon up-and-down method, 17 the present study demonstrated that the bolus ED 50 of ketamine for preventing withdrawal movement on injection of rocuronium after thiopental anaesthesia was 0.21 ± 0.07 mg/kg. In adults, Mahajan et al. 15 reported that the incidence of pain due to injection of rocuronium was reduced significantly by administration of 20 mg ketamine compared with 10 mg ketamine (12% versus 40% incidence of pain, respectively), suggesting that the effect of ketamine in attenuating withdrawal movement is dose dependent. In 1-to 6-year-old paediatric patients, Liou et al. 16 demonstrated that pretreatment with 0.2 mg/kg ketamine reduced the frequency of withdrawal movement from 83% to 27%. The ED 50 of ketamine found in the present study by probit analysis (0.18 mg/kg) is broadly consistent with that reported by Liou et al. 16 The ED 95 of ketamine determined by probit analysis in the present study was 0.33 mg/kg, with a large confidence interval. The up-and-down method is known to be less reliable for calculating small or large percentage points, such as the ED 95 ; 18, 19 however, the ED 95 was probably more relevant than the ED 50 in the present study, in terms of determining the dose that would consistently prevent withdrawal movements and its associated risks after injection of rocuronium.
In previous studies, the reported incidence of withdrawal movements observed during rocuronium injection after administration of anaesthetic agents (thiopental in most studies) in paediatric patients has ranged from 84% to 100%. 1,5,12 -14,16,20 Ruetsch and Borgeat 21 pointed out the possibility of an observational bias because thiopental itself can cause pain on injection and withdrawal movements; however, the use of these two agents is common in clinical settings and determination of the bolus effective dose of ketamine is, therefore, of practical clinical benefit. In the present study, no response and movement at the wrist only were considered to indicate successful prevention of withdrawal movements, as wrist movement rarely causes complications in the clinical setting.
The anaesthetic ketamine is a noncompetitive N-methyl-D-aspartate receptor antagonist that also has analgesic properties. The decreased incidence of pain or withdrawal movement after injection of rocuronium following pretreatment with lowdose ketamine may be produced at the level of the central or peripheral nervous system, as ketamine has both central analgesic effects and a peripheral local anaesthetic action. 22 In the present study, ketamine pretreatment was given without occlusion of intravenous flow. In a study of withdrawal movement after rocuronium with lignocaine pretreatment, the effect of lignocaine was significantly decreased when intravenous flow was not occluded compared with administration during complete occlusion (incidence of withdrawal movement 54% versus 4%), 14 suggesting that occlusion is necessary for peripheral local anaesthetic action. The attenuation of pain without occlusion of intravenous flow seen in the present study is, therefore, more likely to be the result of a central analgesic effect. In addition, the local anaesthetic action of ketamine occurs at high doses, 22 whereas low-dose ketamine was used in the present study, again pointing to a central effect.
In conclusion, the bolus ED 50 of ketamine for preventing withdrawal movement after injection of rocuronium following thiopental anaesthesia was 0.21 mg/kg according to the modified Dixon up-and-down method. 17 Using probit analysis, ED 50 of ketamine was
